Back to results
US 9,238,066 B2Granted
Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
AssigneeRutgers, The State University of New Jersey
InventorMaria L. Gennaro
Life of this patent
Estimating the term…
Abstract
The present invention is directed to reagents useful for generating immune responses to Mycobacterium tuberculosis and for diagnosing infection and disease in a subject that has been exposed to M. tuberculosis.
Claims8
A method of in vitro diagnosis that discriminates between infection by Mycobacterium tuberculosis-complex and vaccination by Bacille Calmette Guerin (BCG) strain of Mycobacterium bovis comprising:
- providing a population of cells comprising CD4 T lymphocytes from a subject and antigen presenting cells (APC) expressing at least one major histocompatibility complex (MHC) class II molecule expressed by said subject;
- contacting cells of the population with at least two different antigens, wherein the antigens are isolated polypeptides of the Mycobacterium tuberculosis-complex that are not encoded by BCG, including at least one isolated polypeptide selected from the group consisting of (i) a first amino acid sequence comprising the sequence of MTBN4 (SEQ ID NO:
- 4), (ii) a second amino acid sequence that is an antigenic segment of MTBN4 and (iii) a third amino acid sequence that is identical to said first or second amino acid sequence but that has conservative substitutions and that retains Mycobacterium tuberculosis-complex specific antigenic properties;
- and
- determining whether or not there has been an immune response to said at least two antigens.
2 more elements
Dependencies are inferred from the claim text.